A Quality Improvement Approach to Optimizing Medication Use in the Neonatal Intensive Care Unit
| Autor: | Dan L. Ellsbury, Robert Ursprung |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
Quality management Neonatal intensive care unit Drug-Related Side Effects and Adverse Reactions Birth weight Iatrogenic Disease Gestational Age Context (language use) Infant Newborn Diseases law.invention Iatrogenesis Patient safety Randomized controlled trial law Intensive Care Units Neonatal medicine Birth Weight Humans Medication Errors Neonatology Intensive care medicine Dose-Response Relationship Drug business.industry Infant Newborn Obstetrics and Gynecology medicine.disease Quality Improvement Pharmaceutical Preparations Pediatrics Perinatology and Child Health Emergency medicine Patient Safety business |
| Zdroj: | Clinics in Perinatology. 39:1-10 |
| ISSN: | 0095-5108 |
| DOI: | 10.1016/j.clp.2011.12.001 |
| Popis: | Despite many years of heavy use in premature and critically ill newborns, surprisingly few medications have been rigorously tested in neonatal multicenter randomized clinical trials. Little is known about the pharmacology of these drugs at various birth weights, gestational ages, and chronologic ages. This article describes a quality improvement approach to evaluating and improving neonatal intensive care unit (NICU) medication use, with an emphasis on adaptation of drug use to the specific clinical NICU context and use of system-based changes to minimize harm and maximize clinical benefit. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|